Vanderbilt team to test lasso peptides for ovarian cancer
Vanderbilt-Ingram Cancer Center receives a $450,000 grant to develop lasso peptide therapies that enhance immunotherapy response in ovarian cancer.
Vanderbilt-Ingram Cancer Center receives a $450,000 grant to develop lasso peptide therapies that enhance immunotherapy response in ovarian cancer.
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.